Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 067 243.7 |
96 | EP file number | EAKZ | 15 79 1298.1 |
86 | WO file number | WAKZ | PCT/EP2015/076111 |
97 | EP publication number | EPN | 3218406 |
87 | WO publication number | WPN | 2016075099 |
54 | Designation/title | TI | FÜR CD73 SPEZIFISCHE BINDEMOLEKÜLE UND VERWENDUNGEN DAVON |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/40 (2006.01), A61K 39/00 (2006.01), A61K 47/68 (2017.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01) |
22 | DE application date | DAT | Nov 9, 2015 |
96 | EP application date | EAT | Nov 9, 2015 |
86 | WO application date | WAT | Nov 9, 2015 |
43 | Date of first publication | OT | May 19, 2016 |
| Date of publication of grant | PET | Mar 24, 2021 |
71/73 | Applicant/owner | INH | Medimmune Limited, Cambridge, Cambridgeshire, GB |
72 | Inventor | IN | MINTER, Ralph, Cambridge Cambridgeshire CB21 6GH, GB; RUST, Steven, Cambridge Cambridgeshire CB21 6GH, GB; GUILLARD, Sandrine, Cambridge Cambridgeshire CB21 6GH, GB; JERMUTUS, Lutz U, Cambridge Cambridgeshire CB21 6GH, GB; HAY, Carl, Gaithersburg, MD 20878, US; SACHSENMEIER, Kris, Gaithersburg, MD 20878, US; SULT, Erin, Gaithersburg, MD 20878, US; HUANG, Qihui, Gaithersburg, MD 20878, US; PAVLIK, Peter, Gaithersburg, MD 20878, US; DAMSCHRODER,Melissa, Gaithersburg, MD 20878, US; CHENG, Li, Gaithersburg, MD 20878, US; DIEDRICH, Gundo, Gaithersburg, MD 20878, US; RIOS-DORIA, Jonathan, Gaithersburg, MD 20878, US; HAMMOND, Scott, Gaithersburg, MD 20878, US; HOLLINGSWORTH, Robert E, Gaithersburg, MD 20878, US; DURHAM, Nicholas, Gaithersburg, MD 20878, US; LEOW, Ching Ching, Gaithersburg, MD 20878, US; ANTONYSAMY, Mary, Gaithersburg, MD 20878, US; GEOGHEGAN, James, Gaithersburg, MD 20878, US; LU, Xiaojun, Gaithersburg, MD 20878, US; ROSENTHAL, Kim, Gaithersburg, MD 20878, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562147329 P Apr 14, 2015
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201462077486 P Nov 10, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562188999 P Jul 6, 2015
|
| Due date | FT FG | Nov 30, 2025 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003218406A1 Searchable text:
EP000003218406A1 Original document:
EP000003218406B1 Searchable text:
EP000003218406B1 Original document:
EP000003218406B2 Searchable text:
EP000003218406B2 Original document:
WO002016075099 Searchable text:
WO002016075099 |
43 | Date of first publication | EVT | May 19, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Sep 21, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 1, 2024 (Show all update days)(Hide all update days)- Oct 1, 2024
- Due date: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 02.10.2024: changed
- Sep 12, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 02.10.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 02.10.2024: new
- Procedures: Procedure relating to PCT application, Publication of PCT application, 19.05.2016: deleted
- Mar 28, 2024; Sep 22, 2023; Sep 20, 2022; Jan 5, 2022; Dec 2, 2021; Nov 26, 2021; Jun 10, 2021; Apr 15, 2021; Mar 5, 2021; Mar 4, 2021; Oct 8, 2020
- Historical data not available for this/these date(s)
- Sep 21, 2017
- Date of the first transfer into DPMAregister
|